Key benefits

  • Unique quantification of Fetomaternal Hemorrhage by flow cytometry
  • Complete assay, ready to use
  • Simple and easy handling procedure
  • FETALtrol™ available as a system control


  • Double discrimination between fetal cells and maternal HbF+ cells
  • Detection as low as 0.014% fetal cells in maternal blood
  • Based on the patented combination of antibodies against fetal hemoglobin and carbonic anhydrase
  • Results in 90 minutes
  • Registered as Medical Device for In Vitro Diagnostic Use (IVD/CE)


  • Determination of Fetomaternal Hemorrhage
  • Pregnancy with suspected RhD incompatibilities
  • Abdominal trauma

More info